Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia (Q51738077)

11 April 2018

title

Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

20 November 2024

0 references

0 references

1 reference

Eunice S. Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21176961

20 November 2024

George Deeb

1 reference

11 April 2018

Ian McInnis

1 reference

11 April 2018

Laurie Ann Ford

1 reference

11 April 2018

Petr Starostik

1 reference

11 April 2018

Meir Wetzler

1 reference

11 April 2018

Terry Mashtare

1 reference

11 April 2018

Mary M. Vaughan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21176961

20 November 2024

Sheila N. J. Sait

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21176961

20 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21176961

20 November 2024

publication date

21 December 2010

1 reference

11 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0145212610005138?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

https://api.elsevier.com/content/article/PII:S0145212610005138?httpAccept=text/plain

20 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

20 November 2024

1 reference

11 April 2018

volume

1 reference

11 April 2018

issue

1 reference

11 April 2018

page(s)

579-584

1 reference

11 April 2018

Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1042/BJ20070286

Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.0812801106

Targeting HIF-1 for cancer therapy

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Physiological hypoxia promotes lipid raft and PI3K-dependent activation of MAPK 42/44 in leukemia cells

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Oxygen saturation in the bone marrow of healthy volunteers

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

The hematopoietic stem cell niche: low in oxygen but a nice place to be.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Bone marrow microvessel density and its prognostic significance in AML

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter?

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis Assay

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Autocrine VEGF loops, signaling pathways, and acute leukemia regulation.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Metabolism and the leukemic stem cell.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia-HIF-1alpha-C/EBPalpha/Runx1 signaling in leukemic cell differentiation

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

HIF-1alpha protein is an essential factor for protection of myeloid cells against LPS-induced depletion of ATP and apoptosis that supports Toll-like receptor 4-mediated production of IL-6.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

A three-gene signature for outcome in soft tissue sarcoma

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Targeting tumor angiogenesis with histone deacetylase inhibitors

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors

20 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.020

20 November 2024

Identifiers

1 reference

11 April 2018

1 reference

11 April 2018